Cargando…
Significance of Preexisting Vector Immunity and Activation of Innate Responses for Adenoviral Vector-Based Therapy
An adenoviral (AdV)-based vector system is a promising platform for vaccine development and gene therapy applications. Administration of an AdV vector elicits robust innate immunity, leading to the development of humoral and cellular immune responses against the vector and the transgene antigen, if...
Autores principales: | Wang, Wen-Chien, Sayedahmed, Ekramy E., Mittal, Suresh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787786/ https://www.ncbi.nlm.nih.gov/pubmed/36560730 http://dx.doi.org/10.3390/v14122727 |
Ejemplares similares
-
Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
por: Sayedahmed, Ekramy E., et al.
Publicado: (2020) -
Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
por: Alhashimi, Marwa, et al.
Publicado: (2021) -
Adenoviral vector‐based platforms for developing effective vaccines to combat respiratory viral infections
por: Elkashif, Ahmed, et al.
Publicado: (2021) -
A Bovine Adenoviral Vector-Based H5N1 Influenza -Vaccine Provides Enhanced Immunogenicity and Protection at a Significantly Low Dose
por: Sayedahmed, Ekramy E., et al.
Publicado: (2018) -
Xenogenic Adenoviral Vectors
por: Mittal, Suresh K., et al.
Publicado: (2016)